Valeant under scrutiny for doubling price of assisted suicide drug sold in U.S.

Valeant under scrutiny for doubling price of assisted suicide drug sold in U.S.

Add Comment Edit

Valeant Death Drug 20160325

Valeant Pharmaceuticals, accused by U.S. politicians of price-gouging, is facing criticism from assisted-dying advocates across North America for doubling the price of a drug commonly used to hasten death soon after California legalized doctor-assisted suicide.



from CBC | Health News http://ift.tt/1XT4Ef8

Share this:

ABOUT THE AUTHOR

Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible

0 commentaires:

Enregistrer un commentaire

Inscription à : Publier les commentaires ( Atom )